ストックスクリーナーアプリを入手
19.97
1.47%
0.29
前日終値:
$19.68
開ける：
$19.81
24時間の取引高:
556.12K
Relative Volume:
1.14
時価総額：
$1.08B
収益：
$2.22M
当期純損益:
$-40.51M
株価収益率:
-15.54
EPS:
-1.2847
ネットキャッシュフロー:
$-46.53M
1週間 パフォーマンス:
+16.58%
1か月 パフォーマンス:
+28.84%
6か月 パフォーマンス:
+135.77%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$19.09
$20.42
1週間の範囲:
$16.66
$21.03
52週間の値動き範囲:
$5.14
$29.46
Upstream Bio Inc Stock (UPB) Company Profile
UPB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
UPB
Upstream Bio Inc
|
19.97 | 1.06B | 2.22M | -40.51M | -46.53M | -1.2847 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Upstream Bio Inc Stock (UPB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-05 | 開始されました | JP Morgan | Overweight |
| 2024-11-05 | 開始されました | Piper Sandler | Overweight |
| 2024-11-05 | 開始されました | TD Cowen | Buy |
| 2024-11-05 | 開始されました | William Blair | Outperform |
Upstream Bio Inc (UPB) 最新ニュース
Visual trend scoring systems applied to Upstream Bio Inc.M&A Rumor & Daily Stock Trend Reports - Newser
Upstream Bio Inc. stock momentum explainedWeekly Profit Analysis & Stepwise Entry and Exit Trade Signals - Newser
Historical volatility pattern of Upstream Bio Inc. visualizedEarnings Miss & Community Supported Trade Ideas - Newser
Statistical indicators supporting Upstream Bio Inc.’s strength2025 Analyst Calls & Technical Confirmation Trade Alerts - Newser
Using portfolio simulators with Upstream Bio Inc. included2025 Buyback Activity & Expert Verified Stock Movement Alerts - Newser
How to interpret RSI for Upstream Bio Inc. stock2025 Market Sentiment & Safe Entry Trade Reports - Newser
Upstream Bio’s Phase 2 VIBRANT Trial Results and Strategic Implications for Long-Term Growth - AInvest
Is Upstream Bio Inc. stock poised for growthMarket Performance Summary & Consistent Profit Focused Trading Strategies - Newser
Is now a turning point for Upstream Bio Inc.Portfolio Gains Report & Accurate Buy Signal Notifications - Newser
Will Upstream Bio Inc. benefit from geopolitical trendsJuly 2025 Catalysts & Short-Term Swing Trade Alerts - خودرو بانک
Can Upstream Bio Inc. outperform in the next rally2025 Trading Volume Trends & AI Powered Buy and Sell Recommendations - خودرو بانک
Long term hold vs stop loss in Upstream Bio Inc.Price Action & Free Technical Confirmation Trade Alerts - Newser
Is Upstream Bio Inc. stock a top performer YTDWeekly Trend Report & Free Safe Capital Growth Stock Tips - خودرو بانک
Transcript : Upstream Bio, Inc.Special Call - MarketScreener
Is Upstream Bio Inc. forming a bottoming baseJuly 2025 Market Mood & Real-Time Stock Movement Alerts - Newser
Trend analysis for Upstream Bio Inc. this weekPortfolio Growth Summary & Real-Time Chart Pattern Alerts - Newser
Using economic indicators to assess Upstream Bio Inc. potentialJuly 2025 Retail & AI Enhanced Trade Execution Alerts - Newser
Technical signs of recovery in Upstream Bio Inc.2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - Newser
Exit strategy if you’re trapped in Upstream Bio Inc.Trade Entry Summary & Verified Short-Term Plans - Newser
Upstream Bio Initiates Phase 2 Clinical Trial for COPD Drug, Verekitug - MSN
What MACD and RSI say about Upstream Bio Inc.2025 Major Catalysts & AI Powered Buy/Sell Recommendations - Newser
How to build a dashboard for Upstream Bio Inc. stock2025 Top Gainers & Fast Gain Stock Tips - Newser
Real time breakdown of Upstream Bio Inc. stock performanceMarket Performance Recap & High Accuracy Swing Entry Alerts - Newser
Analyzing Upstream Bio Inc. with risk reward ratio chartsWeekly Profit Analysis & High Conviction Buy Zone Alerts - Newser
Does Upstream Bio Inc. offer margin of safetyMarket Risk Report & Capital Efficiency Focused Strategies - خودرو بانک
Will Upstream Bio Inc. outperform during market ralliesMarket Sentiment Report & Daily Entry Point Trade Alerts - خودرو بانک
Upstream Bio Inc. stock outlook for YEAR2025 Momentum Check & High Win Rate Trade Alerts - Newser
Is Upstream Bio Inc. a strong candidate for buy and holdQuarterly Trade Review & Reliable Breakout Stock Forecasts - خودرو بانک
Upstream Bio Announces Positive Phase 2 Trial Results - The Globe and Mail
Developing predictive dashboards with Upstream Bio Inc. dataRate Cut & Technical Pattern Recognition Alerts - Newser
Is Upstream Bio Inc. meeting your algorithmic filter criteriaDay Trade & Free Community Consensus Stock Picks - Newser
Upstream Bio shares rise 1.18% premarket after reporting positive top-line results from the Phase 2 VIBrant trial of Verekitug for the treatment of chronic rhinosinusitis with nasal polyps. - AInvest
Upstream Bio, Inc. $UPB Shares Sold by Charles Schwab Investment Management Inc. - Defense World
Signal strength of Upstream Bio Inc. stock in tech scannersRecession Risk & Low Drawdown Investment Ideas - Newser
Upstream Bio Reports Positive Top-Line Results from the - GlobeNewswire
Upstream Bio Shares Surge 18.27% on Strong Phase 2 Trial Data for Verekitug - AInvest
Technical Heatmap Flags Upstream Bio Inc. for WatchCPI Data & Safe Entry Zone Tips - beatles.ru
Verekitug heads to late-stage trials after Phase II success - Yahoo Finance
Upstream's New Sinus Treatment Cuts Need For Surgery, Early Trial FindsUpstream Bio (NASDAQ:UPB) - Benzinga
Upstream Bio’s Phase 2 win could set it up as a potential Dupixent, Tezspire competitor - Endpoints News
Positive Buy Rating for Upstream Bio, Inc. Driven by Promising Clinical Trial Results for Verekitug - TipRanks
Upstream Bio Inc (UPB) 財務データ
収益
当期純利益
現金流量
EPS
1.40%
大文字化:
|
ボリューム (24 時間):